Search / Trial NCT06221397

Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma

Launched by AI LABS GROUP S.L · Jan 23, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Melanoma Primary Care Dermatology Diagnosis Artificial Intelligence Severity

Description

Introduction Cutaneous melanoma (CM), a type of skin cancer, has seen a significant rise in incidence and mortality. It\'s particularly aggressive and can metastasize rapidly, making it resistant to chemotherapy and radiotherapy. However, early detection through simple surgical excision is highly treatable. Differentiating between benign and malignant pigmented lesions, especially during visual examination, is challenging. Due to low public awareness and limited access to dermatologists, melanoma often gets diagnosed at a later stage. To address this, there\'s growing interest in c...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with skin lesions with suspected malignancy
  • * Age over 18 years old
  • * Patients who consent to participate in the study by signing the Informed Consent form
  • Exclusion Criteria:
  • * Patients under 18 years of age

About Ai Labs Group S.L

ai labs group s.l. is an innovative clinical trial sponsor dedicated to advancing healthcare through the integration of artificial intelligence and data-driven methodologies. With a focus on enhancing the efficiency and reliability of clinical research, the organization collaborates with a diverse range of stakeholders, including pharmaceutical companies, research institutions, and healthcare providers. By leveraging cutting-edge technology and a multidisciplinary approach, ai labs group s.l. aims to streamline clinical trial processes, improve patient outcomes, and accelerate the development of new therapies. Their commitment to ethical research practices and regulatory compliance ensures that all clinical trials meet the highest standards of safety and efficacy.

Locations

Barakaldo, Biscay, Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0